3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE
CAS215187-35-2
3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE (CAS 215187-35-2, C14H16N2O2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 215187-35-2
- Formula
- C14H16N2O2
- Mol. weight
- 244.28 g/mol
Chemical Specifications
Identifiers
| CAS number | 215187-35-2 |
|---|---|
| Product name | 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE |
| Synonyms | N-BOC-B-NORNICOTRYINE |
| Molecular formula | C14H16N2O2 |
| Molecular weight | 244.28 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE?
The CAS Registry Number of 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE is 215187-35-2. 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE is also known as N-BOC-B-NORNICOTRYINE.
What is the molecular formula and molecular weight of 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE?
The molecular formula of 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE is C14H16N2O2, and its molecular weight is 244.28 g/mol.
How can I request a quotation for 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE?
Send an inquiry for 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE (CAS 215187-35-2) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 3-O-BENZYL-1,2-O-ISOPROPYLIDENE-A-D-GLUCOFURANOSE
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.